274 related articles for article (PubMed ID: 37450246)
1. Different Chronic Stress Paradigms Converge on Endogenous TDP43 Cleavage and Aggregation.
Candelise N; Caissutti D; Zenuni H; Nesci V; Scaricamazza S; Salvatori I; Spinello Z; Mattei V; Garofalo T; Ferri A; Valle C; Misasi R
Mol Neurobiol; 2023 Nov; 60(11):6346-6361. PubMed ID: 37450246
[TBL] [Abstract][Full Text] [Related]
2. Interaction of RNA with a C-terminal fragment of the amyotrophic lateral sclerosis-associated TDP43 reduces cytotoxicity.
Kitamura A; Nakayama Y; Shibasaki A; Taki A; Yuno S; Takeda K; Yahara M; Tanabe N; Kinjo M
Sci Rep; 2016 Jan; 6():19230. PubMed ID: 26757674
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal full-length antibody against TAR DNA binding protein 43 reduces related proteinopathy in neurons.
Pozzi S; Codron P; Soucy G; Renaud L; Cordeau PJ; Dutta K; Bareil C; Julien JP
JCI Insight; 2020 Nov; 5(21):. PubMed ID: 33021970
[TBL] [Abstract][Full Text] [Related]
4. An optimized InCell Western screening technique identifies hexachlorophene as a novel potent TDP43 targeting drug.
Narayan M; Peralta DA; Gibson C; Zitnyar A; Jinwal UK
J Biotechnol; 2015 Aug; 207():34-8. PubMed ID: 25987361
[TBL] [Abstract][Full Text] [Related]
5. Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis.
Pokrishevsky E; Grad LI; Yousefi M; Wang J; Mackenzie IR; Cashman NR
PLoS One; 2012; 7(4):e35050. PubMed ID: 22493728
[TBL] [Abstract][Full Text] [Related]
6. The proteinopathy of D169G and K263E mutants at the RNA Recognition Motif (RRM) domain of tar DNA-binding protein (tdp43) causing neurological disorders: A computational study.
Bhandare VV; Ramaswamy A
J Biomol Struct Dyn; 2018 Mar; 36(4):1075-1093. PubMed ID: 28330421
[TBL] [Abstract][Full Text] [Related]
7. Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy.
Cortese A; Plagnol V; Brady S; Simone R; Lashley T; Acevedo-Arozena A; de Silva R; Greensmith L; Holton J; Hanna MG; Fisher EM; Fratta P
Neurobiol Aging; 2014 Jun; 35(6):1491-8. PubMed ID: 24462217
[TBL] [Abstract][Full Text] [Related]
8. Triad of TDP43 control in neurodegeneration: autoregulation, localization and aggregation.
Tziortzouda P; Van Den Bosch L; Hirth F
Nat Rev Neurosci; 2021 Apr; 22(4):197-208. PubMed ID: 33654312
[TBL] [Abstract][Full Text] [Related]
9. TDP43 and RNA instability in amyotrophic lateral sclerosis.
Weskamp K; Barmada SJ
Brain Res; 2018 Aug; 1693(Pt A):67-74. PubMed ID: 29395044
[TBL] [Abstract][Full Text] [Related]
10. Shortened TDP43 isoforms upregulated by neuronal hyperactivity drive TDP43 pathology in ALS.
Weskamp K; Tank EM; Miguez R; McBride JP; Gómez NB; White M; Lin Z; Gonzalez CM; Serio A; Sreedharan J; Barmada SJ
J Clin Invest; 2020 Mar; 130(3):1139-1155. PubMed ID: 31714900
[TBL] [Abstract][Full Text] [Related]
11. The N Termini of TAR DNA-Binding Protein 43 (TDP43) C-Terminal Fragments Influence Degradation, Aggregation Propensity, and Morphology.
Kasu YAT; Alemu S; Lamari A; Loew N; Brower CS
Mol Cell Biol; 2018 Oct; 38(19):. PubMed ID: 29987190
[TBL] [Abstract][Full Text] [Related]
12. Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies.
Cascella R; Capitini C; Fani G; Dobson CM; Cecchi C; Chiti F
J Biol Chem; 2016 Sep; 291(37):19437-48. PubMed ID: 27445339
[TBL] [Abstract][Full Text] [Related]
13. TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia.
Archbold HC; Jackson KL; Arora A; Weskamp K; Tank EM; Li X; Miguez R; Dayton RD; Tamir S; Klein RL; Barmada SJ
Sci Rep; 2018 Mar; 8(1):4606. PubMed ID: 29545601
[TBL] [Abstract][Full Text] [Related]
14. TDP43 proteinopathy is associated with aberrant DNA methylation in human amyotrophic lateral sclerosis.
Appleby-Mallinder C; Schaber E; Kirby J; Shaw PJ; Cooper-Knock J; Heath PR; Highley JR
Neuropathol Appl Neurobiol; 2021 Feb; 47(1):61-72. PubMed ID: 32365404
[TBL] [Abstract][Full Text] [Related]
15. Both cytoplasmic and nuclear accumulations of the protein are neurotoxic in Drosophila models of TDP-43 proteinopathies.
Miguel L; Frébourg T; Campion D; Lecourtois M
Neurobiol Dis; 2011 Feb; 41(2):398-406. PubMed ID: 20951205
[TBL] [Abstract][Full Text] [Related]
16. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death.
Xiao S; Sanelli T; Chiang H; Sun Y; Chakrabartty A; Keith J; Rogaeva E; Zinman L; Robertson J
Acta Neuropathol; 2015 Jul; 130(1):49-61. PubMed ID: 25788357
[TBL] [Abstract][Full Text] [Related]
17. TDP43 pathology in the brain, spinal cord, and dorsal root ganglia of a patient with FOSMN.
Rossor AM; Jaunmuktane Z; Rossor MN; Hoti G; Reilly MM
Neurology; 2019 Feb; 92(9):e951-e956. PubMed ID: 30700593
[TBL] [Abstract][Full Text] [Related]
18. Mutated FUS in familial amyotrophic lateral sclerosis involves multiple hnRNPs in the formation of neuronal cytoplasmic inclusions.
Honda H; Yoshimura M; Arahata H; Yagita K; Sadashima S; Hamasaki H; Shijo M; Koyama S; Noguchi H; Sasagasako N
J Neuropathol Exp Neurol; 2023 Feb; 82(3):231-241. PubMed ID: 36592411
[TBL] [Abstract][Full Text] [Related]
19. ALS-associated TDP-43 induces endoplasmic reticulum stress, which drives cytoplasmic TDP-43 accumulation and stress granule formation.
Walker AK; Soo KY; Sundaramoorthy V; Parakh S; Ma Y; Farg MA; Wallace RH; Crouch PJ; Turner BJ; Horne MK; Atkin JD
PLoS One; 2013; 8(11):e81170. PubMed ID: 24312274
[TBL] [Abstract][Full Text] [Related]
20. Modulation of assembly of TDP-43 low-complexity domain by heparin: From droplets to amyloid fibrils.
Garg DK; Bhat R
Biophys J; 2022 Jul; 121(13):2568-2582. PubMed ID: 35644946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
